The Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System is the only FDA-approved CGM System that lets you make treatment decisions without pricking your finger.* It provides real-time glucose readings for patients with type 1 or type 2 diabetes every five minutes. With Dexcom G5 Mobile, dynamic glucose data can be accessed and shared safely and conveniently anywhere, anytime to your smart device.† The Dexcom G5 Mobile is the only CGM system approved for adults and pediatric patients two years of age and older.
*CGM-based treatment requires fingersticks for calibration, if patient is taking acetaminophen, or if symptoms/expectations do not match CGM readings, and if not performed, may result in hypoglycemia.
†For a list of compatible devices, visit http://dexcom.com/compatibility.